US 9,867,871 B2Granted

Composition and method for treating nucleic acid-related eye disease

AssigneeThe Board of Trustees of the University of Illinois

InventorSandeep Jain

Life of this patent

Estimating the term…

Abstract

Provided herein is a composition and a method for treating nucleic acid-related eye disease.

Claims9

Dependent claims

A method for the treatment of a nucleic acid-related eye disease, comprising administering an effective amount of a composition to the surface of the eye to remove nucleic acid from the surface of the eye, wherein the composition comprises a nuclease and an ophthalmic excipient;

wherein the nuclease is a DNase, an RNase or a combination thereof, and wherein the composition does not contain an antibiotic.

Dependencies are inferred from the claim text.

Facts

Application: 14/362,589Filed 20 Aug 2012 · us provisional application
Priority: 12 Dec 2011
Published: US 2015/0010524 A18 Jan 2015
Granted: 16 Jan 2018
Term ends: Not estimatedThe source records don’t support an estimate.

Classification16 codes

A61K 38/465
Hydrolases: acting on ester bonds , e.g. lipases, ribonucleases
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears
A61K 31/465
Having six-membered rings with one nitrogen as the only ring hetero atom: nicotine; Derivatives thereof
A61K 45/05
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: immunological preparations stimulating the…

Family

Application61/569,604Us provisional application · filed 12 Dec 2011
Application61/600,377Us provisional application · filed 17 Feb 2012
US 2015/0010524 A1Pre-grant publication · published 8 Jan 2015
US 9,867,871 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results